Urologix Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$24 K |
Shares Outstanding |
21.82 M |
Public Float |
- |
Address |
14405 21st Avenue North Minneapolis Minnesota 55447 United States |
Employees | - |
Website | - |
Updated | 07/08/2019 |
Urologix, Inc. develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN. |